期刊文献+

丙戊酸抗裸鼠Kasumi-1细胞移植瘤血管新生的作用研究 被引量:4

Effect of Valproic Acid against Angiogenesis of Kasumi-1 Xenograft Tumor in Nude Mice
下载PDF
导出
摘要 本研究旨在探讨组蛋白去乙酰化酶抑制剂丙戊酸(VPA)体内、体外抑制急性髓系白血病血管新生及其作用机制。用不同浓度的VPA处理人t(8;21)急性白血病细胞株Kasumi-1细胞3 d后用RT-PCR及Western blot分析细胞Ang1、Ang2 mRNA及蛋白水平的变化;建立Kasumi-1细胞裸鼠移植瘤模型,采用RT-PCR、Western blot的方法分析对照组和VPA治疗组瘤组织Ang1、Ang2、VEGF mRNA及蛋白水平的变化,免疫组织化学的方法分析瘤组织CD34及Ang1、Ang2蛋白水平的改变。结果表明,VPA 1-3 mmol/L处理3 d能够下调Kasumi-1细胞Ang1 mRNA(3 mmol/L组0.040±0.008,对照组0.360±0.116)、Ang2 mRNA(3 mmol/L组0.146±0.038,对照组0.540±0.049)及蛋白的相对表达,呈浓度依赖性;VPA 500 mg/kg,ip,处理14 d能够明显降低裸鼠瘤组织Ang1、Ang2、VEGF mRNA及蛋白的相对表达(P<0.01),并能明显减少荷Kasumi-1细胞裸鼠移植瘤微血管密度(8.470±0.300vs 2.600±0.200)。结论:VPA可能通过调节血管生成素及VEGF的表达,阻碍白血病的血管新生,从而抑制白血病细胞浸润、迁移。 This study was aimed to investigate the effect of valproic acid( VPA), a histone deacetylase inhibitor, on angiogenesis of acute myeloid leukemia in vivo and vitro, and to explore its molecular mechanism. Human t(8 ;21 ) AML cell line Kasumi-1 cells were treated with VPA at different concentration for 3 d, the mRNA and protein expression levels of Angl and Ang2 were determined by semi-quantitative RT-PCR and Western blot respectively. Nude mice model with xenograft Kasumi-1 tumor was established by subcutaneous inoculation of Kasumi-1 cells. The CD34, Angl and Ang2 protein levels were analyzed by immunohistochemistry method. The mRNA and protein expression levels of Angl, Ang2 and VEGF were determined by semi-quantitative RT-PCR and Western blot. The results showed that in vitro, VPA at 3 mmol/L downregulated the Ang mRNA relative expression level for Angl from 0.360 ±0. 116 to 0.040 ±0.008, Ang2 from 0.540 ±0.049 to 0. 146 ±0.038. The animal experiment further verified that VPA 500 mg/kg, ip, for 14 d, reduced the relative expression of Angl ,Ang2 and VEGF mRNA and proteins in Kasumi-1 tumor of nude mice, and reduced microvascullar density in xenograft tumor of nude mice (8.470± 0.300 vs 2.600 ±0.200). It is concluded that VPA significantly inhibits tumor angiogenesis through the regulation of angiopoietins, thereby inhibits the proliferation and metastasis of leukemia cells.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2013年第1期73-77,共5页 Journal of Experimental Hematology
基金 河北省自然科学基金项目(编号C2008000660)
关键词 丙戊酸 急性髓系白血病 Kasumi-1细胞株 血管内皮生长因子 血管生成素 valproic acid AML Kasumi-1 cell line vascular endothelial growth factor angiopoietin
  • 相关文献

参考文献3

二级参考文献30

  • 1郝长来,林冬,王莉红,邢海燕,王敏,王建祥.苯丁酸钠联合5-氮杂脱氧胞苷抑制Kasumi-1细胞裸鼠移植瘤的生长[J].中华血液学杂志,2004,25(11):658-661. 被引量:7
  • 2Tnis MR,Yang L,Suarez Saiz F,et al.The histone deacelyase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.Leukemia,2005,19:1161 -1168.
  • 3Koolwijk P,van Erck MG,de Vree WJ.et al.Cooperative effect of TNF alpha,bFGF,and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix:role of urkinase activity.J Cell Biol,1996,132:1177-1188.
  • 4Dias S.Hattori K,Heissig B,et al.Inhibition of both paracrine and autocrine VEGF/VEGFR2-signaling pathways is essential to induce longterm remission of xenotransplanted human leukemias.Proc Natl Acad Sci U S A,2001,98:10857-10862.
  • 5Asou H,Tashiro S,Hamamoto K,et al.Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8 ;21 chromosome translocation.Blood,1991,77:2031-2036.
  • 6Hiramatsu A.Miwa H,Shikami M,et al.Disease-specific expression of VEGF and its receptors in AML cells; possible autocrine pathway of VEGF/typel receptor of VEGF in t(15 ;17) AML and VEGF/type2 receptor of VEGF in t(8:21) AML.Leuk Lympho-ma,2006,47:89-95.
  • 7Deroanne CF,Bonjean K,Servotte S,et al.Histone deacetylase inhibitors as anti-angiogenic agents altering vascular endothial growth factor signaling.Oncogene,2002,21:427-436.
  • 8Sasakawa Y,Naoe Y,Noto T,et al.Antitumor efficacy of FK228,a novel histone deacetylase inhibitor,depends on the effect on expression of angiogenesis factors.Biochemical Pharmacol,2003,66:897-906.
  • 9Kang JH,Kim SA,Chang SY,et al.Inhibition of trichostatin A-induced antiangi-ogenesis by small-interfering RNA for throm-bospondin-1.Exp Mol Med,2007,3:402-411.
  • 10Ellis L,Hammers H,Pili R.Targeting tumor angiogenesis with histone deacetylase inhibitors.Cancer Lett,2009,280:145-153.

共引文献30

同被引文献42

  • 1许晓巍,许小平,易克,陈莉,陈少谊,周芳,李倩玉.地塞米松对三氧化二砷诱导淋巴瘤细胞凋亡与NF-κB活化及相关基因表达的影响[J].中华血液学杂志,2005,26(4):227-231. 被引量:15
  • 2Eklund L,Saharinen P.Angiopoietin signaling in the vasculature.Exp Cell Res,2013;319(9):1271-1280.
  • 3Potente M,Gerhardt H,Carmeliet P.Basic and therapeutic aspects of angiogenesis.Cell,2011;146(6):873-887.
  • 4Hou HA,Chou WC,Lin LI,et al.Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.Leuk Res,2008;32(6):904-912.
  • 5Yuan HT,Khankin EV,Karumanchi SA,et al.Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.Mol Cell Biol,,2009;29(8):2011-2022.
  • 6Eroglu Z,Stein CA,Pal SK.Targeting angiopoietin-2 signaling in cancer therapy.Expert Opin Investig Drugs,2013;22(7):813-825.
  • 7Plate KH,Scholz A,Dumont DJ.Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.Acta Neuropathologica,2012;124(6):763-775.
  • 8Trollope AF,Golledge J.,Angiopoietins,abdominal aortic aneurysm and atherosclerosis.Atherosclerosis,2011;214(2):237-243.
  • 9Maffei R,Martinelli S,Santachiara R,et al.Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.Blood,2010;116(4):584-592.
  • 10Fushida S,Oyama K,Kinoshita J,et al.VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer:prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody.Onco Targets Ther,2013;6:1445-1451.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部